One of the few women to lead a large global biopharma company, Kewalramani, who is also a doctor, took charge at Boston-based Vertex in April 2020. The maker of four breakthrough cystic fibrosis ...

On tonight's call making prepared remarks, we have Dr. Reshma Kewalramani, Vertex's CEO and president; Stuart Arbuckle, chief ...

Jeffrey Leiden is leaving Vertex Pharma after seven years as president and CEO, to be replaced by chief medical officer Reshma Kewalramani. Leiden isn’t heading off into the sunset, however.

Loved for her rich voice and quirky style, Reshma was the life of weddings Last week, Reshma, an iconic trans woman and a singer in Indian-administered Kashmir, died after a long battle with cancer.

Dr. Reshma Kewalramani, Chief Executive Officer and President, will participate in a fireside chat at the Guggenheim Inaugural Healthcare Innovation Conference on Tuesday, November 12, 2024 at 9: ...

Reshma Kewalramani, the CEO and President of Vertex Pharmaceuticals Inc. (NASDAQ:VRTX), recently sold 15,198 shares of the company's common stock. The transaction, which took... ByInvesting.com ...

On tonight’s call, making prepared remarks, we have Dr. Reshma Kewalramani, Vertex’s CEO and President; Stuart Arbuckle, Chief Operating Officer; and Charlie Wagner, Chief Financial Officer.

On tonight’s call, making prepared remarks, we have Dr. Reshma Kewalramani, Vertex’s CEO and President; Stuart Arbuckle, ...